protagonist-inc.com (PTGX) - שווי החברה ברכישה מלאה

This price trend reflects the enterprise value of Protagonist Therapeutics (PTGX), which currently stands at 8358.28. The high margin potential of Protagonist Therapeutics (PTGX) is protected by patents for innovative peptides. The business is based on creating oral drug formulations that combine antibody properties with ease of administration, which is highly sought after in the therapy of rare blood pathologies. The company's strategy relies on integrating cutting-edge developments into the product lines of global pharmaceutical behemoths.

Retaining key peptide biotechnology specialists and the R&D core of Protagonist Therapeutics (PTGX) creates a long-term intellectual asset that is capitalized into the business value. The current value of 8358.28 reflects the total acquisition cost of the company, combining market capitalization with net debt, which allows for an assessment of the real price for acquiring all operational capacities through the EV history.